Literature DB >> 15372097

Prostanoids and blood pressure: which way is up?

Helene Francois1, Thomas M Coffman.   

Abstract

Members of the family of prostanoids, made up of prostaglandins and thromboxanes, are generated via COX-mediated metabolism of arachidonic acid. These lipid mediators exhibit wide-ranging biological actions that include regulating both vasomotor tone and renal sodium excretion. As COX inhibition is often associated with sodium retention leading to edema and hypertension, prostanoids appear to have a role in preventing the development of high blood pressure. On the other hand, prostaglandin E2 (PGE2) and PGI2 have also been implicated as determinants of renin secretion. A new study suggests that PGI2 plays a critical role in stimulating renin release and promoting hypertension following renal artery stenosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372097      PMCID: PMC516269          DOI: 10.1172/JCI22929

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Biomechanical coupling in renin-releasing cells.

Authors:  R M Carey; H E McGrath; E S Pentz; R A Gomez; P Q Barrett
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 2.  Prostanoid receptors: structures, properties, and functions.

Authors:  S Narumiya; Y Sugimoto; F Ushikubi
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

3.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

4.  Differential regulation of renal cyclooxygenase mRNA by dietary salt intake.

Authors:  B L Jensen; A Kurtz
Journal:  Kidney Int       Date:  1997-11       Impact factor: 10.612

5.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

Review 6.  Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.

Authors:  P W de Leeuw
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

7.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

8.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

Authors:  B F McAdam; F Catella-Lawson; I A Mardini; S Kapoor; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

9.  In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs.

Authors:  H Oida; T Namba; Y Sugimoto; F Ushikubi; H Ohishi; A Ichikawa; S Narumiya
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.

Authors:  J H Gurwitz; J Avorn; R L Bohn; R J Glynn; M Monane; H Mogun
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

View more
  12 in total

1.  Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis.

Authors:  Marina Korotkova; Nina A Daha; Maria Seddighzadeh; Bo Ding; Anca I Catrina; Staffan Lindblad; Tom W J Huizinga; Rene E M Toes; Lars Alfredsson; Lars Klareskog; Per-Johan Jakobsson; Leonid Padyukov
Journal:  Eur J Hum Genet       Date:  2011-03-30       Impact factor: 4.246

Review 2.  The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Tilo Grosser; Emanuela Ricciotti; Garret A FitzGerald
Journal:  Trends Pharmacol Sci       Date:  2017-06-23       Impact factor: 14.819

3.  Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.

Authors:  Yu Pan; Shirong Cao; Andrew S Terker; Jiaqi Tang; Kensuke Sasaki; Yinqiu Wang; Aolei Niu; Wentian Luo; Xiaofeng Fan; Suwan Wang; Matthew H Wilson; Ming-Zhi Zhang; Raymond C Harris
Journal:  Kidney Int       Date:  2021-11-11       Impact factor: 10.612

4.  Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney.

Authors:  Ildikó Toma; Jung Julie Kang; Arnold Sipos; Sarah Vargas; Eric Bansal; Fiona Hanner; Elliott Meer; János Peti-Peterdi
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

5.  Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.

Authors:  Dairong Wang; Vickas V Patel; Emanuela Ricciotti; Rong Zhou; Mark D Levin; Ehre Gao; Zhou Yu; Victor A Ferrari; Min Min Lu; Junwang Xu; Hualei Zhang; Yiqun Hui; Yan Cheng; Nataliya Petrenko; Ying Yu; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

6.  The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background.

Authors:  Carie S Facemire; Robert Griffiths; Laurent P Audoly; Beverly H Koller; Thomas M Coffman
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

7.  11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis.

Authors:  Shilin Yang; Li Jiang; Ming-Zhi Zhang
Journal:  J Oncobiomarkers       Date:  2013

Review 8.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

9.  Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Heart Int       Date:  2006-09-30

10.  Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend.

Authors:  J Al-Bishri; Sm Attar; Nawal Bassuni; Yasser Al-Nofaiey; Hamed Qutbuddeen; Salma Al-Harthi; Sarah Subahi
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.